Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation.
Limited quarterly history available
Gross Margin needs at least three reported quarters before a meaningful chart is shown.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
N/A
GROSS MARGIN AVG 3Y
N/A
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Hemab Therapeutics Holdings, Inc. Common Stock
Market Cap
$1.33B
Gross Margin
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.37B
Gross Margin
-91.00%
TTM Avg
-566.75%
3Y Avg
-1506.60%
5Y Avg
-994.02%
Market Cap
$1.39B
Gross Margin
14.79%
TTM Avg
13.21%
3Y Avg
12.77%
5Y Avg
12.70%
Market Cap
$1.40B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.40B
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
75.15%
5Y Avg
50.10%
Market Cap
$1.24B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG) | $1.33B | 0.00% | N/A | N/A | N/A |
| Omeros Corporation (OMER)vs › | $1.34B | 0.00% | 0.00% | 0.00% | 0.00% |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.31B | 0.00% | 0.00% | 0.00% | 0.00% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.37B | -91.00% | -566.75% | -1506.60% | -994.02% |
| The Pennant Group, Inc. (PNTG)vs › | $1.39B | 14.79% | 13.21% | 12.77% | 12.70% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.40B | N/A | N/A | N/A | N/A |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.40B | 0.00% | 0.00% | 0.00% | 0.00% |
| Taysha Gene Therapies, Inc. (TSHA)vs › | $1.40B | 100.00% | 100.00% | 75.15% | 50.10% |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | 0.00% | 0.00% | 0.00% | 0.00% |
| Omada Health (OMDA)vs › | $1.23B | 68.19% | 63.14% | 57.81% | 57.81% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
